Jorieke Weiden

2.6k total citations · 1 hit paper
19 papers, 2.0k citations indexed

About

Jorieke Weiden is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Jorieke Weiden has authored 19 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 9 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Jorieke Weiden's work include Immunotherapy and Immune Responses (11 papers), CAR-T cell therapy research (7 papers) and RNA Interference and Gene Delivery (5 papers). Jorieke Weiden is often cited by papers focused on Immunotherapy and Immune Responses (11 papers), CAR-T cell therapy research (7 papers) and RNA Interference and Gene Delivery (5 papers). Jorieke Weiden collaborates with scholars based in Netherlands, United States and Switzerland. Jorieke Weiden's co-authors include Seth B. Coffelt, Jos Jonkers, Karin E. de Visser, Metamia Ciampricotti, Cheei‐Sing Hau, Lukas J.A.C. Hawinkels, Kim Vrijland, Niels J. M. Verstegen, Chris W. Doornebal and Kelly Kersten and has published in prestigious journals such as Nature, Nature Materials and ACS Nano.

In The Last Decade

Jorieke Weiden

19 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis

2015 1.3k citations Seth B. Coffelt, Kelly Kersten et al. Nature profile →

Peers

Countries citing papers authored by Jorieke Weiden

Since Specialization

Citations

This map shows the geographic impact of Jorieke Weiden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jorieke Weiden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jorieke Weiden more than expected).

Fields of papers citing papers by Jorieke Weiden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jorieke Weiden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jorieke Weiden. The network helps show where Jorieke Weiden may publish in the future.

Co-authorship network of co-authors of Jorieke Weiden

This figure shows the co-authorship network connecting the top 25 collaborators of Jorieke Weiden. A scholar is included among the top collaborators of Jorieke Weiden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jorieke Weiden. Jorieke Weiden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Stabilizing Polymer Coatings Alter the Protein Corona of DNA Origami and Can Be Engineered to Bias the Cellular Uptake 2023 ·ACS Polymers Au ·(unknown), Jorieke Weiden, Maartje M. C. Bastings	8
2	The Swiss Young Immunologists Society (SYIS): Empowering the next generation of immunologists 2023 ·European Journal of Immunology ·Daniela Latorre, Annika Hausmann, Sinduya Krishnarajah, Jorieke Weiden, (unknown), (unknown), (unknown)	2
3	Balancing the Nanoscale Organization in Multivalent Materials for Functional Inhibition of the Programmed Death-1 Immune Checkpoint 2023 ·ACS Nano ·(unknown), Jorieke Weiden, (unknown), Alexandra S. Eklund, S. Reinhardt, Ian A. Parish, Ralf Jungmann, Maartje M. C. Bastings	19
4	Insights in the host response towards biomaterial-based scaffolds for cancer therapy 2023 ·Frontiers in Bioengineering and Biotechnology ·(unknown), Jorieke Weiden, Martijn Verdoes, Carl G. Figdor	6
5	Dictating Phenotype, Function, and Fate of Human T Cells with Co‐Stimulatory Antibodies Presented by Filamentous Immune Cell Mimics 2022 ·Advanced Therapeutics ·(unknown), Loek J. Eggermont, Jorieke Weiden, (unknown), L. Weiss, Bas Pilzecker, (unknown), (unknown), (unknown), Martijn Verdoes, Carl G. Figdor, Roel Hammink	6
6	Human type 1 and type 2 conventional dendritic cells express indoleamine 2,3‐dioxygenase 1 with functional effects on T cell priming 2021 ·European Journal of Immunology ·Simone P. Sittig, Jasper J. P. van Beek, Georgina Flórez‐Grau, Jorieke Weiden, Sonja I. Buschow, (unknown), (unknown), Marcel M. Verbeek, (unknown), Johannes Textor, Carl G. Figdor, I. Jolanda M. de Vries, Gerty Schreibelt	21
7	Semiflexible Immunobrushes Induce Enhanced T Cell Activation and Expansion 2021 ·ACS Applied Materials & Interfaces ·Roel Hammink, Jorieke Weiden, (unknown), (unknown), Loek J. Eggermont, (unknown), Carl G. Figdor, Martijn Verdoes	22
8	Robust Antigen-Specific T Cell Activation within Injectable 3D Synthetic Nanovaccine Depots 2021 ·ACS Biomaterials Science & Engineering ·Jorieke Weiden, (unknown), (unknown), Eric A. W. van Dinther, Mahboobeh Rezaeeyazdi, (unknown), (unknown), (unknown), Jurjen Tel, Mustafa Diken, Sidi A. Bencherif, Carl G. Figdor, Martijn Verdoes	5
9	DNA origami nanostructures for controlled therapeutic drug delivery 2020 ·Current Opinion in Colloid & Interface Science ·Jorieke Weiden, Maartje M. C. Bastings	61
10	Synthetic Semiflexible and Bioactive Brushes 2019 ·Biomacromolecules ·(unknown), (unknown), Jorieke Weiden, Ben Joosten, Loek J. Eggermont, (unknown), (unknown), Alessandra Cambi, Carl G. Figdor, Paul H. J. Kouwer, Martijn Verdoes, Roel Hammink, Alan E. Rowan	11
11	Biomaterial-Based Activation and Expansion of Tumor-Specific T Cells 2019 ·Frontiers in Immunology ·(unknown), Roel Hammink, Carl G. Figdor, Martijn Verdoes, Jorieke Weiden	18
12	Injectable Biomimetic Hydrogels as Tools for Efficient T Cell Expansion and Delivery 2018 ·Frontiers in Immunology ·Jorieke Weiden, (unknown), Yusuf Dölen, Rajat Kumar Das, Anne van Duffelen, Roel Hammink, Loek J. Eggermont, Alan E. Rowan, Jurjen Tel, Carl G. Figdor	70
13	Dendritic cells in cancer immunotherapy 2018 ·Nature Materials ·Camille M. Le Gall, Jorieke Weiden, Loek J. Eggermont, Carl G. Figdor	102
14	Substrate stiffness influences phenotype and function of human antigen-presenting dendritic cells 2017 ·Scientific Reports ·(unknown), Matteo Bolomini‐Vittori, Jorieke Weiden, Ben Joosten, Alessandra Cambi, Koen van den Dries	88
15	Synthetic immune niches for cancer immunotherapy 2017 ·Nature reviews. Immunology ·Jorieke Weiden, Jurjen Tel, Carl G. Figdor	149
16	A membrane-anchored aptamer sensor for probing IFNγ secretion by single cells 2017 ·Chemical Communications ·Liping Qiu, Florian Wimmers, Jorieke Weiden, Hans A. Heus, Jurjen Tel, Carl G. Figdor	54
17	A Comparative Study of the T Cell Stimulatory and Polarizing Capacity of Human Primary Blood Dendritic Cell Subsets 2016 ·Mediators of Inflammation ·(unknown), Ghaith Bakdash, Jorieke Weiden, Annette E. Sköld, Jurjen Tel, (unknown), I. Jolanda M. de Vries, Gerty Schreibelt	55
18	Abstract IA29: Towards synthetic immune cells for cancer immunotherapy 2016 ·Cancer Immunology Research ·Carl G. Figdor, Subhra Mandal, Roel Hammink, Loek J. Eggermont, Jorieke Weiden, (unknown), Jurjen Tel, Zaskia H. Eksteen-Akeroyd, Kerstin G. Blank, Alan E. Rowan	3
19	IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis breakdown → 2015 ·Nature ·Seth B. Coffelt, Kelly Kersten, Chris W. Doornebal, Jorieke Weiden, Kim Vrijland, Cheei‐Sing Hau, Niels J. M. Verstegen, Metamia Ciampricotti, Lukas J.A.C. Hawinkels, Jos Jonkers, Karin E. de Visser	1295

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact